Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Operating Expenses | 22,343 | 23,581 | 20,882 | 15,923 | 18,979 |
| Operating Income | -22,343 | -23,581 | -20,882 | -15,923 | -18,979 |
| Other Income | 194 | 204 | 198 | 234 | 221 |
| Pre-tax Income | -22,149 | -23,377 | -20,684 | -15,689 | -18,758 |
| Net Income Continuous | -22,149 | -23,377 | -20,684 | -15,689 | -18,758 |
| Net Income | $-22,149 | $-23,377 | $-20,684 | $-15,689 | $-18,758 |
| EPS Basic Total Ops | -0.35 | -0.37 | -0.33 | -0.33 | -1.15 |
| EPS Basic Continuous Ops | -0.35 | -0.37 | -0.33 | -0.27 | -0.32 |
| EPS Diluted Total Ops | -0.35 | -0.37 | -0.33 | -0.33 | -1.15 |
| EPS Diluted Continuous Ops | -0.35 | -0.37 | -0.33 | -0.27 | -0.32 |
| EBITDA(a) | $-22,115 | $-23,329 | $-20,633 | $-15,638 | $-18,900 |